구유정 조교수
#갑상선 질환#고지혈증#골대사 #기타 내분비계 질환#당뇨
|
학력
경북대학교 의과대학 졸업
서울대학교 의과대학 임상의과학과 석사 수료
서울대학교 의과대학 중개의학과 박사 재학
서울대학교 의과대학 임상의과학과 석사 수료
서울대학교 의과대학 중개의학과 박사 재학
경력
서울대학교병원 인턴 수료
서울대학교병원 내과 전문의 과정 수료
분당서울대학교병원 내분비내과 임상강사
현 충북대학교병원 내분비내과 임상조교수
서울대학교병원 내과 전문의 과정 수료
분당서울대학교병원 내분비내과 임상강사
현 충북대학교병원 내분비내과 임상조교수
논문
논문 내용이 없습니다.
저서
저서 내용이 없습니다.
보도자료
국내 연구팀 "혈액검사로 당뇨병 발생 예측 가능"
http://www.dailymedi.com/detail.php?number=853404&thread=22r03
http://www.dailymedi.com/detail.php?number=853404&thread=22r03
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
Ku EJ, Park JI, Jeon HJ, Oh TK, Choi HJ. Clinical efficacy and plausibility of a smartphone-based integrated online real-time diabetes care system via glucose and diet data management: A pilot study. Intern Med J. 2020 Jan 6 [Online ahead of print]
Ku EJ*, Cho KC*, Lim C, Kang JW, Oh JW, Choi YR, Park JM, Han NY, Oh JJ, Oh TJ, Jang HC, Lee H, Kim KP, Choi SH. Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics. BMJ Open Diabetes Res Care. 2020 Apri8(1):e001152.
Ku EJ, Won GW, Lee YH, Lee DH, Jeon HJ, Oh TK. Genetic variation in TCF7L2 rs7903146 correlating with peripheral arterial disease in long-standing type 2 diabetes. Diab Vasc Dis Res. 2020 Jan-Feb17(1):1479164119888475.
Cho NH*, Ku EJ*1, Jung KY, Oh TJ, Kwak SH, Moon JH, Park KS, Jang HC, Kim YJ, Choi SH. Estimated association between cytokines and the progression to diabetes: 10-year follow-up from a community-based cohort. J Clin Endocrinol Metab. 2020 Mar 1105(3):e381-9.
Ku EJ, Lee DH, Jeon HJ, Oh TK.. Empagliflozin versus dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin, glimepiride and dipeptidyl peptidase 4 inhibitors: A 52-week prospective observational study. Diabetes Res Clin Pract. 2019 May151:65-73
Ku EJ, Lee DH, Jeon HJ, Oh TK. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glarging-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice. Diabetes Obes Metab. 2019 Jan21(1):173-177.
Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang HC, Lim S, Ahren B. Four-year durability of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes in clinical practice COSMIC Study. PLoS One. 2015 Jun 1210(6):e0129477.
Choi SH*, Ku EJ*, Hong ES, Lim S, Kim KW, Moon JH, Kim KM, Park YJ, Park KS, Jang HC. High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, "adiponectin paradox": the Korean Longitudinal Study on Health and Aging (KLoSHA). Int J Cardiol. 2015 Mar 1518391-7.
Ku EJ, Hong AR, Kim YA, Bae JH, Chang MS, Kim SW. Adrenocorticotopic hormone-independent Cushing syndrome with bilateral cortisol-secreting adenomas. Endocrinol Metab (Seoul) 2013 Jun28(2):133-7.
Ku EJ*, Cho KC*, Lim C, Kang JW, Oh JW, Choi YR, Park JM, Han NY, Oh JJ, Oh TJ, Jang HC, Lee H, Kim KP, Choi SH. Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics. BMJ Open Diabetes Res Care. 2020 Apri8(1):e001152.
Ku EJ, Won GW, Lee YH, Lee DH, Jeon HJ, Oh TK. Genetic variation in TCF7L2 rs7903146 correlating with peripheral arterial disease in long-standing type 2 diabetes. Diab Vasc Dis Res. 2020 Jan-Feb17(1):1479164119888475.
Cho NH*, Ku EJ*1, Jung KY, Oh TJ, Kwak SH, Moon JH, Park KS, Jang HC, Kim YJ, Choi SH. Estimated association between cytokines and the progression to diabetes: 10-year follow-up from a community-based cohort. J Clin Endocrinol Metab. 2020 Mar 1105(3):e381-9.
Ku EJ, Lee DH, Jeon HJ, Oh TK.. Empagliflozin versus dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin, glimepiride and dipeptidyl peptidase 4 inhibitors: A 52-week prospective observational study. Diabetes Res Clin Pract. 2019 May151:65-73
Ku EJ, Lee DH, Jeon HJ, Oh TK. Effectiveness and safety of empagliflozin-based quadruple therapy compared with insulin glarging-based therapy in patients with inadequately controlled type 2 diabetes: An observational study in clinical practice. Diabetes Obes Metab. 2019 Jan21(1):173-177.
Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang HC, Lim S, Ahren B. Four-year durability of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes in clinical practice COSMIC Study. PLoS One. 2015 Jun 1210(6):e0129477.
Choi SH*, Ku EJ*, Hong ES, Lim S, Kim KW, Moon JH, Kim KM, Park YJ, Park KS, Jang HC. High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, "adiponectin paradox": the Korean Longitudinal Study on Health and Aging (KLoSHA). Int J Cardiol. 2015 Mar 1518391-7.
Ku EJ, Hong AR, Kim YA, Bae JH, Chang MS, Kim SW. Adrenocorticotopic hormone-independent Cushing syndrome with bilateral cortisol-secreting adenomas. Endocrinol Metab (Seoul) 2013 Jun28(2):133-7.